References
- PrattLABrodyDJDepression in the U.S. household population, 2009–2012NCHS Data Brief201417218
- CuijpersPSmitFExcess mortality in depression: a meta-analysis of community studiesJ Affect Disorders200272322723612450639
- RuoBRumsfeldJSHlatkyMALiuHBrownerWSWhooleyMADepressive symptoms and health-related quality of life: the heart and Soul StudyJAMA2003290221522112851276
- KhawajaISWestermeyerJJGajwaniPFeinsteinREDepression and coronary artery disease, the association, mechanisms and therapeutic implicationsPsychiatry (Edgmont)2009613851
- ZivinKIlgenMAPfeifferPNEarly mortality and years of potential life lost among veterans affairs patients with depressionPsychiatr Serv201263882382622854727
- ChesneyEGoodwinGMFazelSRisks of all-cause and suicide mortality in mental disorders: a meta-reviewWorld Psychiatry201413215316024890068
- KesslerRCFrankRGThe impact of psychiatric disorders on work loss daysPsychol Med19972748618739234464
- BroadheadWEBlazerDGGeorgeLKTseCKDepression, disability days, and days lost from work in a prospective epidemiologic surveyJAMA199026419252425282146410
- GreenbergPEFournierAASisitskyTPikeCTKesslerRCThe economic burden of adults with major depressive disorder in the United States (2005 and 2010)J Clin Psychiatry201576215516225742202
- SimonGEVonKorffMBarlowWHealth care costs of primary care patients with recognized depressionArch Gen Psychiatry199552108508567575105
- U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health StatisticsHealth, United States, 2013: with special feature on prescription drugs Available from: https://www.cdc.gov/nchs/data/hus/hus13.pdfAccessed February 10, 2017
- Centerwatch.org [internet]Boston, MA Available from: https://www.centerwatch.com/drug-information/fda-approved-drugs/therapeutic-area/17/psychiatry-psychologyAccessed May 16, 2017
- MrazekDAPsychiatric pharmacogenomic testing in clinical practiceDialogues Clin Neurosci2010121697620373668
- RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
- TrivediMHRushAJWisniewskiSRSTAR*DStudy TeamEvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D implications for clinical practiceAm J Psychiatry20061631284016390886
- HuynhNNMcIntyreRSWhat are the implications of the STAR*D Trial for primary care? A review and synthesisPrim Care Companion J Clin Psychiatry2008102919618458732
- Mental Health Care Health Professional Shortage Areas (HPSAs) The Henry JKaiser Family Foundation Available from: http://kff.org/other/state-indicator/mental-health-care-health-professional-shortage-areas-hpsas/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7DAccessed April 3, 2017
- 2012 Physician Specialty Data Book Center for Workforce StudiesWashington, DCAssociation of American Medical Colleges2012
- KesslerRCBerglundPDemlerOJinRMerikangasKRWaltersEELifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry200562659360215939837
- MarkTLLevitKRBuckJAPsychotropic drug prescriptions by medical specialtyPsychiatr Serv2009609116719723729
- BradleyPShiekhMMehraVImproved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: a randomized clinical trial demonstrating clinical utilityJ Psychiatr Res20179610010728992526
- OlsonMCMacielAGariepyJFClinical impact of pharmacogenetic-guided treatment for patients exhibiting neuropsychiatric disorders: a randomized controlled trialPrim Care Companion CNS Disord2017192
- Hall-FlavinDKWinnerJGAllenJDUtility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingPharmacogenet Genomics2013231053554824018772
- SaldivarJSTaylorDSugarmanEAInitial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facilityPharmacogenomics Pers Med2016916
- ZhouZWChenXWSneedKBClinical association between pharmacogenomics and adverse drug reactionsDrugs201575658963125895462
- SugarmanEACullorsACentenoJTaylorDContribution of pharmacogenetic testing to modeled medication change recommendations in a long-term care population with polypharmacyDrugs Aging2016331292993627826798
- WinnerJAllenJDAltarCASpahic-MihajlovicAPsychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depressionTransl Psychiatry20133e24223511609
- ChouWHYanFXdeLeonJExtension of a pilot study: impact from the cytochrome P4502D6 polymorphism on outcome and costs associated with severe mental illnessJ Clin Psychopharmacol200020224625110770465